(Q38206111)

31 August 2017

0 references

Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses (English)

1 reference

31 August 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

Xiang Cheng

1

1 reference

31 August 2017

Ping Sun

2

1 reference

31 August 2017

Qing-Gang Hu

3

1 reference

31 August 2017

Zi-Fang Song

4

1 reference

31 August 2017

Jun Xiong

5

1 reference

31 August 2017

Qi-Chang Zheng

6

1 reference

31 August 2017

publication date

22 April 2014

1 reference

Journal of Cancer Research and Clinical Oncology

31 August 2017

published in

1 reference

31 August 2017

volume

140

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

1159-1170

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-014-1677-4

31 August 2017

exact match

0 references

cites work

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1677-4

A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

1 reference

12 December 2020

Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis

1 reference

12 December 2020

Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future

1 reference

12 December 2020

Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma

1 reference

12 December 2020

Tumor necrosis can facilitate the appearance of metastases

1 reference

12 December 2020

Is postoperative chemotherapy effective for the prevention of recurrence after surgery for hepatocellular carcinoma?

1 reference

12 December 2020

A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma

1 reference

12 December 2020

Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus

1 reference

12 December 2020

Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization

1 reference

12 December 2020

Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases

1 reference

12 December 2020

Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival

1 reference

12 December 2020

Recurrence and metastasis of hepatocellular carcinoma: progress and prospects

1 reference

12 December 2020

Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal

1 reference

12 December 2020

An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials

1 reference

12 December 2020

Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy

1 reference

12 December 2020

Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.

1 reference

12 December 2020

10.1007/S00432-014-1677-4

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lthqbha5preyzhfisfijkm4yay

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_lthqbha5preyzhfisfijkm4yay

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lthqbha5preyzhfisfijkm4yay

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/lthqbha5preyzhfisfijkm4yay

1 reference

30 July 2022